PIP
TEVA icon

Perennial Investment Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Perennial Investment Partners’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-38,499
Closed -$1.54M – 77
2013
Q4 		$1.54M Hold
38,499
– – 0.44% 54
2013
Q3 		$1.45M Hold
38,499
– – 0.37% 66
2013
Q2 		$1.51M Buy
+38,499
New +$1.5M 0.39% 60

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Perennial Investment Partners's TEVA Position: Q1 2014 in Review

Perennial Investment Partners sold out of Teva Pharmaceuticals (TEVA) in Q1 2014, closing a stake of 38,499 shares — an estimated $1.54M sold.

Perennial Investment Partners first reported a position in TEVA in Q2 2013 and held it in 3 quarters. The position peaked at $1.54M in Q4 2013. 771 funds tracked by Wall St. Rank hold TEVA as of Q1 2014.

  • Perennial Investment Partners reported no remaining Teva Pharmaceuticals position as of Q1 2014 after selling out during the quarter.
  • Perennial Investment Partners sold 38,499 Teva Pharmaceuticals shares in Q1 2014, an estimated $1.54M.
  • Perennial Investment Partners first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 3 quarters.
  • Perennial Investment Partners's Teva Pharmaceuticals position peaked at $1.54M in Q4 2013.
  • 771 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2014.

Based on Perennial Investment Partners's 13F filing for Q1 2014, filed 15 May 2014.